A quantitative sensory analysis of peripheral neuropathy in colorectal cancer and its exacerbation by oxaliplatin chemotherapy - Wikidata - awgldk - TriplyDB

A quantitative sensory analysis of peripheral neuropathy in colorectal cancer and its exacerbation by oxaliplatin chemotherapy

A quantitative sensory analysis of peripheral neuropathy in colorectal cancer and its exacerbation by oxaliplatin chemotherapy

http://www.wikidata.org/entity/Q34438547

about

Mechanisms involved in the development of chemotherapy-induced neuropathy AAPT Diagnostic Criteria for Chronic Cancer Pain Conditions Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment Scale Preventive effect of oral goshajinkigan on chronic oxaliplatin-induced hypoesthesia in rats Prechemotherapy Touch Sensation Deficits Predict Oxaliplatin-Induced Neuropathy in Patients with Colorectal Cancer.Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral Neuropathy A randomized exploratory phase 2 study in patients with chemotherapy-related peripheral neuropathy evaluating whole-body vibration training as adjunct to an integrated program including massage, passive mobilization and physical exercises Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives.Update on Chemotherapy-Induced Peripheral Neuropathy.Can Stopping Nerves, Stop Cancer?The Use of Sensory Analysis Techniques to Assess the Quality of Indoor Air.Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study.Chronic Pain and Neuropathy Following Adjuvant Chemotherapy.Multimodal quantitative examination of nerve function in colorectal cancer patients prior to chemotherapy.Pain in Platin-Induced Neuropathies: A Systematic Review and Meta-Analysis.Chemokine CCL2 and its receptor CCR2 in the dorsal root ganglion contribute to oxaliplatin-induced mechanical hypersensitivity.Oxaliplatin-induced blood brain barrier loosening: a new point of view on chemotherapy-induced neurotoxicity.Gaps in Understanding Mechanism and Lack of Treatments: Potential Use of a Nonhuman Primate Model of Oxaliplatin-Induced Neuropathic Pain.

P2860

Q26824380-10709550-7A16-4BC3-AA87-63E9B3A99C4C Q28079708-DF03274C-E90F-430A-A3C4-DAAE94FB050B Q36117942-00A9A74F-1A23-4E71-A938-0CDE45FF35EF Q36254642-4A0B46B4-C020-4B3F-8647-674C4147F240 Q36693127-CC71B4B9-0F1E-483A-B355-8525CE8A98EF Q37081502-515A6C88-465D-49CD-86B2-330412E4834A Q37631063-39EB9BF0-3381-4D06-A5B3-9BAF82CD490E Q38522262-ADAC4C2F-40F4-46FF-A147-20570429DDD5 Q38728572-1B49E1BA-4DCE-49A3-9F7A-311EF5C5F7DE Q38796646-61E762E0-295B-4293-AFE3-047FE8F24AB2 Q38814916-1B2D10FD-D5F0-4630-A715-FDCC99EF5145 Q41346602-38779B52-3C12-449C-A85E-C83EE3DA9550 Q47894849-979C7119-E415-439C-8695-44FCF8BB56A8 Q48020601-F5B3FB15-8D10-43CC-8FDA-37D5445064E4 Q48192466-3CD6F0A6-2578-4C9E-88D9-77C6913907E6 Q52648842-55625D8B-B82A-49E1-9FFC-442D91D50811 Q55003322-9AB6EDE0-0600-4077-A51D-98D5C8AC73C3 Q55364011-9B8113B5-AB88-46FF-8816-5AD7CB6598E4

P2860

A quantitative sensory analysis of peripheral neuropathy in colorectal cancer and its exacerbation by oxaliplatin chemotherapy

http://www.wikidata.org/entity/Q34438547

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A quantitative sensory analysi ...... on by oxaliplatin chemotherapy

@ast

A quantitative sensory analysi ...... on by oxaliplatin chemotherapy

@en

A quantitative sensory analysi ...... on by oxaliplatin chemotherapy

@nl

type

label

A quantitative sensory analysi ...... on by oxaliplatin chemotherapy

@ast

A quantitative sensory analysi ...... on by oxaliplatin chemotherapy

@en

A quantitative sensory analysi ...... on by oxaliplatin chemotherapy

@nl

prefLabel

A quantitative sensory analysi ...... on by oxaliplatin chemotherapy

@ast

A quantitative sensory analysi ...... on by oxaliplatin chemotherapy

@en

A quantitative sensory analysi ...... on by oxaliplatin chemotherapy

@nl

P1433

Q34438547-2F3BBDA6-6985-48B0-9787-7D9D57B374CE

P1476

Q34438547-E5604BD2-B31D-4A79-A0D9-A68D31BEF314

P2093

Q34438547-46CD6375-1E3C-44D9-98B8-C87FD8077D7B

Q34438547-5F289759-0522-4CC9-B6F8-65E4CA0BED0B

Q34438547-6BA23D4A-8DD6-4FE1-939F-1580A466F7A4

Q34438547-7E163DC2-E8F8-4C39-AB7D-AB1340FA0DB0

Q34438547-7F9EA7A4-102E-4830-A641-035206251501

Q34438547-8C09956A-965C-4CDC-8E56-69AE1CDC7F04

Q34438547-9FF35243-6B88-4C87-9E1C-96CD6A9788B7

Q34438547-D6E6CC2B-FBCF-4274-A768-DD577F446027

P2860

Q34438547-06B0363D-972A-4FED-83BF-0D649B893C6B

Q34438547-0C8DD5B6-B3C5-4AD0-867D-03EA31B83659

Q34438547-0E417F79-CC2B-4DE7-AC0D-17ED9C8A1CE3

Q34438547-14D8314E-A3A9-4ECE-874D-6ED92A4A2F38

Q34438547-176A427D-4F76-471A-BA0B-04EA9B50EE49

Q34438547-3159897D-3D96-4B21-BE15-F23F8B437772

Q34438547-315AEDD3-2654-4114-925D-D6466D182555

Q34438547-3ADA4AEB-086E-4539-984E-535B716447BE

Q34438547-447E3529-2246-4ED3-9C79-5798BF2DC554

Q34438547-4950565C-CC3F-4D89-929F-4982159815DA

P304

Q34438547-3737F7AC-67BA-4B87-A015-3E093657A9D1

P31

Q34438547-428E0544-A4E5-47D4-BCDC-64C11817D862

P356

Q34438547-E98853B4-CEB0-4245-8504-0C71D919F943

P407

Q34438547-CE094CCA-01F4-423D-9E49-8DE5FEEB5BBC

P433

Q34438547-8F03B33C-70D0-4E31-907C-C0B378CCD89C

P478

Q34438547-736BA758-3EEC-4F1A-9A1F-49CDE8AE50F2

P50

Q34438547-10B4ED6B-B144-44E2-AC23-1ECD97517D04

P577

Q34438547-4E4EB300-0A96-4F4D-A360-D6087F69896F

P698

Q34438547-E40E089C-C451-46A4-86D1-6D180749E2E4

P921

Q34438547-1A2B7A79-DA28-4F64-94AB-DC21A2211B44

Q34438547-584B92FF-AE20-4743-9DD3-F09DC09CA007

P932

Q34438547-51EEB99B-DE8D-4F24-8BD0-EBD5951A4BF0

P356

0008-5472.CAN-14-2060

P1433

Cancer Research

P1476

A quantitative sensory analysi ...... on by oxaliplatin chemotherapy

@en

P2093

Alyssa K Kosturakis

http://www.w3.org/2001/XMLSchema#string

Cathy Eng

http://www.w3.org/2001/XMLSchema#string

Charles S Cleeland

http://www.w3.org/2001/XMLSchema#string

Donald A Simone

http://www.w3.org/2001/XMLSchema#string

Gwen Wendelschafer-Crabb

http://www.w3.org/2001/XMLSchema#string

Mariana de Carvalho Barbosa

http://www.w3.org/2001/XMLSchema#string

William R Kennedy

http://www.w3.org/2001/XMLSchema#string

Xin S Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Merkel cells are essential for light-touch responses.

Piezo2 is required for Merkel-cell mechanotransduction

Endoneurial remodeling by TNFalph- and TNFalpha-releasing proteases. A spatial and temporal co-localization study in painful neuropathy.

Subclinical peripheral neuropathy in patients with multiple myeloma before chemotherapy is correlated with decreased fingertip innervation density

Glial cells as targets for cytotoxic immune mediators.

Intraepidermal nerve fiber loss corresponds to the development of taxol-induced hyperalgesia and can be prevented by treatment with minocycline

A new device to quantify tactile sensation in neuropathy

Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline.

Follow-up psychophysical studies in bortezomib-related chemoneuropathy patients.

Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine

P304

5955-5962

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-14-2060

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P50

Patrick M. Dougherty

P577

2014-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25183707

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

4216766

http://www.w3.org/2001/XMLSchema#string